Protalix BioTherapeutics, Inc. (AMEX:PLX) Q3 2025 Earnings Call Transcript

MSN
2025.11.14 13:32
portai
I'm PortAI, I can summarize articles.

Protalix BioTherapeutics, Inc. (AMEX:PLX) reported its Q3 2025 earnings, missing expectations with an EPS of $0.02914 compared to the expected $0.06.

Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer